Crossmark

Hodgkin lymphoma survivor perspectives on their engagement in treatment decision-making and discussion of late effects

Published Online: 2021-09-15

Published Print: 2022-02

Authors

Murphy-Banks, Rachel

Kumar, Anita J.

Lin, Mingqian

Savidge, Nicole

Livne, Emma

Parsons, Susan K. https://orcid.org/0000-0003-0282-6490
Funding

Funding for this research was provided by:

Leukemia and Lymphoma Society

Foundation for the National Institutes of Health (UL1TR002544)
License Information

Text and Data Mining valid from 2021-09-15

Version of Record valid from 2021-09-15
More Information

Article History

Received: 19 May 2021

Accepted: 5 September 2021

First Online: 15 September 2021

Declarations

:

: The Tufts Health Sciences Institutional Review Board approved this study (#13433).

: Institutional Review Board granted waiver of documentation of consent.

: Yes, according to IRB approval.

: The authors declare no competing interests.

Document is current